Skip to main content

Table 1 Demographic and clinical characteristics

From: Role of preoperative biliary stents, bile contamination and antibiotic prophylaxis in surgical site infections after pancreaticoduodenectomy

Characteristics

All

Non-stented patients

Stented patients

P-value

(N = 180)

(N = 91, 50.6 %)

(N = 89, 49.4 %)

Sex: Female/Male

72/108

40 (55.6)/51 (47.2)

32 (44.4)/57 (52.8)

0.346

Age: <68/≥68 (years)

85/95

44 (51.8)/47 (49.5)

41 (48.2)/48 (50.5)

0.875

Body mass index: <25/≥25 (kg/m2)

112/68

56 (50.0)/35 (51.5)

56 (50.0)/33 (48.5)

0.970

Previous neoplasia: No/Yes

143/37

74 (51.8)/17 (46.0)

69 (48.2)/20 (22.5)

0.657

Surgery for neoplasia: No/Yes

25/155

24 (96.0)/67 (43.2)

1 (4.0)/88 (56.8)

<0.001

Diabetes: No/Yes

144/36

73 (50.7)/18 (50.0)

71 (49.3)/18 (50.0)

1.000

Preoperative jaundice: No/Yes

120/60

78 (65.0)/13 (21.7)

42 (35.0)/47 (78.3)

<0.001

Cardiac disease: No/Yes

155/25

79 (51.0)/12 (48.0)

76 (49.0)/13 (52.0)

0.952

ASA physical status: 1-2/3-4

124/56

66 (53.2)/25 (44.6)

58 (46.8)/31 (55.4)

0.365

Previous antibiotic therapy: No/Yes

166/14

85 (51.2)/6 (42.9)

81 (48.8)/8 (57.1)

0.748

Preoperative CT or RT: No/Yes

170/10

88 (51.8)/3 (30.0)

82 (48.2)/7 (70.0)

0.210*

  1. ASA American Society of Anesthesiologists, CT chemotherapy, RT radiotherapy, *Fisher exact test